Testing effectiveness (Phase 2)UnknownNCT02098720
What this trial is testing
An Open, Single-center, Safety and Efficacy Study of Conbercept in Patients With Very Low Vision Secondary to Wet Age-related Macular Degeneration (wAMD)
Who this might be right for
Very Low Vision Secondary to Wet Age-related Macular Degeneration
Chengdu Kanghong Biotech Co., Ltd. 30